Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
- Posted on August 5, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
